Silence Therapeutics plc : Exercise of warrants

London, 14 January 2013

Exercise of warrants - correction

This replaces the announcement released earlier today, 14 January 2013. This morning's announcement incorrectly stated that ISM had 1.25m warrants remaining. The correct figure is 1.75m.
The Company announces that it has received notice from ISM Capital to exercise warrants over 1,750,000 ordinary shares of 0.1p each at an exercise price of 1 pence per Ordinary Share. Accordingly, the Company will issue, in aggregate, 1,750,000 Ordinary Shares in settlement of this exercise. ISM has 1.75m warrants remaining.
The new Ordinary Shares will rank pari passu with the existing Ordinary Shares and application has been made for the new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective and dealings in the new Ordinary Shares will commence at 8.00 a.m. on 15 January 2013.
Following the Warrant Exercise, the Company's issued share capital will consist of 0.1p
1,873,302,737 Ordinary Shares with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company.

Silence Therapeutics

Tim Freeborn, finance director [phone]

[e-mail]

Singer Capital Markets

Shaun Dobson/Jenny Wyllie

[phone] [e-mail] [e-mail]